MSCI Inc. (NYSE:MSCI) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC raised its stake in MSCI Inc. (NYSE:MSCI) by 48.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 415 shares of the technology company’s stock after acquiring an additional 136 shares during the period. GAMMA Investing LLC’s holdings in MSCI were worth $242,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Rise Advisors LLC purchased a new position in MSCI during the 1st quarter worth approximately $26,000. Rothschild Investment LLC purchased a new position in shares of MSCI during the second quarter worth approximately $26,000. HWG Holdings LP acquired a new position in shares of MSCI in the 2nd quarter valued at $27,000. Crewe Advisors LLC acquired a new position in shares of MSCI in the 1st quarter valued at $34,000. Finally, Ridgewood Investments LLC purchased a new stake in MSCI in the 2nd quarter valued at $40,000. Hedge funds and other institutional investors own 89.97% of the company’s stock.

MSCI Price Performance

Shares of NYSE:MSCI opened at $599.43 on Friday. The firm has a market capitalization of $47.49 billion, a price-to-earnings ratio of 40.92, a price-to-earnings-growth ratio of 2.98 and a beta of 1.11. The business’s 50 day simple moving average is $563.72 and its 200-day simple moving average is $523.87. MSCI Inc. has a 12 month low of $439.95 and a 12 month high of $617.39.

MSCI (NYSE:MSCI) last posted its earnings results on Tuesday, July 23rd. The technology company reported $3.64 EPS for the quarter, topping analysts’ consensus estimates of $3.55 by $0.09. MSCI had a negative return on equity of 143.09% and a net margin of 43.86%. The company had revenue of $707.90 million for the quarter, compared to the consensus estimate of $696.41 million. During the same period in the previous year, the business earned $3.26 earnings per share. MSCI’s quarterly revenue was up 14.0% compared to the same quarter last year. On average, equities analysts anticipate that MSCI Inc. will post 14.79 earnings per share for the current year.

MSCI Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Friday, August 16th were paid a $1.60 dividend. The ex-dividend date of this dividend was Friday, August 16th. This represents a $6.40 dividend on an annualized basis and a yield of 1.07%. MSCI’s payout ratio is 43.69%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on MSCI shares. Morgan Stanley raised their price target on MSCI from $615.00 to $640.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. UBS Group boosted their target price on MSCI from $575.00 to $585.00 and gave the company a “buy” rating in a report on Tuesday, July 9th. Wells Fargo & Company raised MSCI to a “hold” rating in a report on Tuesday, August 13th. The Goldman Sachs Group boosted their price objective on shares of MSCI from $526.00 to $590.00 and gave the company a “neutral” rating in a research note on Wednesday, July 24th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $638.00 target price on shares of MSCI in a research note on Wednesday, July 24th. Seven investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, MSCI currently has an average rating of “Moderate Buy” and an average target price of $612.00.

MSCI Profile

MSCI Inc, together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.